Medication Use Evaluation of Dronedarone in Comparison to Amiodarone
Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...
Main Authors: | Adam Corey, Nita Johnston |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
University of Minnesota Libraries Publishing
2016-12-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Acceso en liña: | https://pubs.lib.umn.edu/index.php/innovations/article/view/480 |
Títulos similares
-
Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
por: Li Y, et al.
Publicado: (2023-12-01) -
Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
por: Mengran Zhang, et al.
Publicado: (2021-08-01) -
Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
por: Li-Qin Jiang, et al.
Publicado: (2016-05-01) -
Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
por: Trigo P, et al.
Publicado: (2011-12-01) -
Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
por: M. Yu. Gilyarov, et al.
Publicado: (2010-12-01)